Read More Analyst Ratings News Price Target Reiteration Credit Suisse Reiterates Outperform on Dover, Maintains $174 Price Target By Benzinga Newsdesk March 9, 8:56 AM Credit Suisse analyst Guy Hardwick reiterates Dover (NYSE:DOV) with a Outperform and maintains $174 price target. DOV
Read More Dividends Earnings News Here’s How Much $1000 Invested In W.W. Grainger 5 Years Ago Would Be Worth Today By Benzinga Insights March 16, 2:00 PM W.W. Grainger (NYSE:GWW) has outperformed the market over the past 5 years by 11.07% on an annualized basis… GWW
Read More News Here’s Why Electronic Arts (EA) Stock Hit A New 52-Week High Today By Henry Khederian July 11, 2:03 PM Electronic Arts Inc (NASDAQ: EA) shares are trading higher by 4.63% to $136.58 Tuesday afternoon. EA
Read More Biotech FDA General News Olema Oncology Announces OP-1250 Demonstrates Attractive Combinability With CDK 4/6 Inhibitor Palbociclib In Phase 1b Dose Escalation Study By Benzinga Newsdesk December 7, 4:39 PM OP-1250 in combination with palbociclib was well-tolerated in patients with ER+/HER2- breast cancer, with no dose-limiting toxicities, and no observed drug-drug interaction No induced metabolism of palbociclib OLMA